LORAIN – Norman “Bud” Milton Werner, 83 years of age, and a resident of Lorain, passed away Monday, January 31, 2011 at New Life Hospice Residential Center in Lorain following a lengthy illness. He ...

Greetings and welcome to Inhibikase Therapeutics First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question and answer session ...

“The financing we concluded in October was a transformational moment for Inhibikase, and positioned us to advance IkT-001Pro into a late-stage clinical trial in Pulmonary Arterial Hypertension (PAH),” ...

BOSTON and ATLANTA, March 07, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase ...

BOSTON and ATLANTA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase ...

“The appointment of Dr. Daifotis and Mr. Young form the cornerstone of ABLi’s governance structure that will position ABLi to become a major force in the development of transformative products to ...

Milton Werner: Thank you, Alex. And thank you, everyone, for joining us today for to review our first quarter 2024 financial results and recent clinical and business updates. 2024 is shipping up to be ...

Milton Werner: Thank you, Alex, and thank you, everybody, for joining the call today. Before I begin, I just want to give a round of applause to our outgoing Chief Financial Officer, Joe Frattaroli, ...